The impact of IPTi and IPTc interventions on malaria clinical burden - in silico perspectives.
BACKGROUND:Clinical management of malaria is a major health issue in sub-Saharan Africa. New strategies based on intermittent preventive treatment (IPT) can tackle disease burden by simultaneously reducing frequency of infections and life-threatening illness in infants (IPTi) and children (IPTc), wh...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2009-08-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2722080?pdf=render |
_version_ | 1818497580564217856 |
---|---|
author | Ricardo Aguas José M L Lourenço M Gabriela M Gomes Lisa J White |
author_facet | Ricardo Aguas José M L Lourenço M Gabriela M Gomes Lisa J White |
author_sort | Ricardo Aguas |
collection | DOAJ |
description | BACKGROUND:Clinical management of malaria is a major health issue in sub-Saharan Africa. New strategies based on intermittent preventive treatment (IPT) can tackle disease burden by simultaneously reducing frequency of infections and life-threatening illness in infants (IPTi) and children (IPTc), while allowing for immunity to build up. However, concerns as to whether immunity develops efficiently in treated individuals, and whether there is a rebound effect after treatment is halted, have made it imperative to define the effects that IPTi and IPTc exert on the clinical malaria scenario. METHODS AND FINDINGS:Here, we simulate several schemes of intervention under different transmission settings, while varying immunity build up assumptions. Our model predicts that infection risk and effectiveness of acquisition of clinical immunity under prophylactic effect are associated to intervention impact during treatment and follow-up periods. These effects vary across regions of different endemicity and are highly correlated with the interplay between the timing of interventions in age and the age dependent risk of acquiring an infection. However, even when significant rebound effects are predicted to occur, the overall intervention impact is positive. CONCLUSIONS:IPTi is predicted to have minimal impact on the acquisition of clinical immunity, since it does not interfere with the occurrence of mild infections, thus failing to reduce the underlying force of infection. On the contrary, IPTc has a significant potential to reduce transmission, specifically in areas where it is already low to moderate. |
first_indexed | 2024-12-10T18:47:15Z |
format | Article |
id | doaj.art-13ff5bf499964663b18333328841f5f2 |
institution | Directory Open Access Journal |
issn | 1932-6203 |
language | English |
last_indexed | 2024-12-10T18:47:15Z |
publishDate | 2009-08-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLoS ONE |
spelling | doaj.art-13ff5bf499964663b18333328841f5f22022-12-22T01:37:27ZengPublic Library of Science (PLoS)PLoS ONE1932-62032009-08-0148e662710.1371/journal.pone.0006627The impact of IPTi and IPTc interventions on malaria clinical burden - in silico perspectives.Ricardo AguasJosé M L LourençoM Gabriela M GomesLisa J WhiteBACKGROUND:Clinical management of malaria is a major health issue in sub-Saharan Africa. New strategies based on intermittent preventive treatment (IPT) can tackle disease burden by simultaneously reducing frequency of infections and life-threatening illness in infants (IPTi) and children (IPTc), while allowing for immunity to build up. However, concerns as to whether immunity develops efficiently in treated individuals, and whether there is a rebound effect after treatment is halted, have made it imperative to define the effects that IPTi and IPTc exert on the clinical malaria scenario. METHODS AND FINDINGS:Here, we simulate several schemes of intervention under different transmission settings, while varying immunity build up assumptions. Our model predicts that infection risk and effectiveness of acquisition of clinical immunity under prophylactic effect are associated to intervention impact during treatment and follow-up periods. These effects vary across regions of different endemicity and are highly correlated with the interplay between the timing of interventions in age and the age dependent risk of acquiring an infection. However, even when significant rebound effects are predicted to occur, the overall intervention impact is positive. CONCLUSIONS:IPTi is predicted to have minimal impact on the acquisition of clinical immunity, since it does not interfere with the occurrence of mild infections, thus failing to reduce the underlying force of infection. On the contrary, IPTc has a significant potential to reduce transmission, specifically in areas where it is already low to moderate.http://europepmc.org/articles/PMC2722080?pdf=render |
spellingShingle | Ricardo Aguas José M L Lourenço M Gabriela M Gomes Lisa J White The impact of IPTi and IPTc interventions on malaria clinical burden - in silico perspectives. PLoS ONE |
title | The impact of IPTi and IPTc interventions on malaria clinical burden - in silico perspectives. |
title_full | The impact of IPTi and IPTc interventions on malaria clinical burden - in silico perspectives. |
title_fullStr | The impact of IPTi and IPTc interventions on malaria clinical burden - in silico perspectives. |
title_full_unstemmed | The impact of IPTi and IPTc interventions on malaria clinical burden - in silico perspectives. |
title_short | The impact of IPTi and IPTc interventions on malaria clinical burden - in silico perspectives. |
title_sort | impact of ipti and iptc interventions on malaria clinical burden in silico perspectives |
url | http://europepmc.org/articles/PMC2722080?pdf=render |
work_keys_str_mv | AT ricardoaguas theimpactofiptiandiptcinterventionsonmalariaclinicalburdeninsilicoperspectives AT josemllourenco theimpactofiptiandiptcinterventionsonmalariaclinicalburdeninsilicoperspectives AT mgabrielamgomes theimpactofiptiandiptcinterventionsonmalariaclinicalburdeninsilicoperspectives AT lisajwhite theimpactofiptiandiptcinterventionsonmalariaclinicalburdeninsilicoperspectives AT ricardoaguas impactofiptiandiptcinterventionsonmalariaclinicalburdeninsilicoperspectives AT josemllourenco impactofiptiandiptcinterventionsonmalariaclinicalburdeninsilicoperspectives AT mgabrielamgomes impactofiptiandiptcinterventionsonmalariaclinicalburdeninsilicoperspectives AT lisajwhite impactofiptiandiptcinterventionsonmalariaclinicalburdeninsilicoperspectives |